173 related articles for article (PubMed ID: 19245803)
1. Effect of sample collection on alpha-galactosidase A enzyme activity measurements in dried blood spots on filter paper.
Olivova P; van der Veen K; Cullen E; Rose M; Zhang XK; Sims KB; Keutzer J; Browning MF
Clin Chim Acta; 2009 May; 403(1-2):159-62. PubMed ID: 19245803
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic diagnosis of Fabry disease using a fluorometric assay on dried blood spots: An alternative methodology.
Caudron E; Prognon P; Germain DP
Eur J Med Genet; 2015 Dec; 58(12):681-4. PubMed ID: 26520229
[TBL] [Abstract][Full Text] [Related]
3. Influence of pre-analytical factors on α-galactosidase A, arylsulfatase B and α-glucosidase activities measured on dried blood spots on filter paper.
de Castilhos CD; Mezzalira J; Goldim MP; Coelho JC
Clin Biochem; 2011 Jul; 44(10-11):922-6. PubMed ID: 21531218
[TBL] [Abstract][Full Text] [Related]
4. Whole-blood alpha-D-galactosidase A activity for the identification of Fabry's patients.
Massaccesi L; Burlina A; Baquero CJ; Goi G; Burlina AP; Tettamanti G
Clin Biochem; 2011 Jul; 44(10-11):916-21. PubMed ID: 21515249
[TBL] [Abstract][Full Text] [Related]
5. Rapid diagnostic testing procedures for lysosomal storage disorders: alpha-glucosidase and beta-galactosidase assays on dried blood spots.
Gasparotto N; Tomanin R; Frigo AC; Niizawa G; Pasquini E; Blanco M; Donati MA; Keutzer J; Zacchello F; Scarpa M
Clin Chim Acta; 2009 Apr; 402(1-2):38-41. PubMed ID: 19111682
[TBL] [Abstract][Full Text] [Related]
6. [Fabry disease: enzymatic screening using dried blood spots on filter paper].
Caudron E; Germain DP; Prognon P
Rev Med Interne; 2010 Dec; 31 Suppl 2():S263-9. PubMed ID: 21211677
[TBL] [Abstract][Full Text] [Related]
7. Anderson-Fabry disease: a case-finding study among male kidney transplant recipients in Austria.
Kleinert J; Kotanko P; Spada M; Pagliardini S; Paschke E; Paul K; Voigtländer T; Wallner M; Kramar R; Stummvoll HK; Schwarz C; Horn S; Holzer H; Födinger M; Sunder-Plassmann G
Transpl Int; 2009 Mar; 22(3):287-92. PubMed ID: 18954370
[TBL] [Abstract][Full Text] [Related]
8. Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry.
Dajnoki A; Fekete G; Keutzer J; Orsini JJ; De Jesus VR; Chien YH; Hwu WL; Lukacs Z; Mühl A; Zhang XK; Bodamer O
Clin Chim Acta; 2010 Oct; 411(19-20):1428-31. PubMed ID: 20338160
[TBL] [Abstract][Full Text] [Related]
9. Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper.
Chamoles NA; Niizawa G; Blanco M; Gaggioli D; Casentini C
Clin Chim Acta; 2004 Sep; 347(1-2):97-102. PubMed ID: 15313146
[TBL] [Abstract][Full Text] [Related]
10. Chitotriosidase determination in plasma and in dried blood spots: a comparison using two different substrates in a microplate assay.
Rodrigues MD; de Oliveira AC; Müller KB; Martins AM; D'Almeida V
Clin Chim Acta; 2009 Aug; 406(1-2):86-8. PubMed ID: 19501579
[TBL] [Abstract][Full Text] [Related]
11. Comparison between alpha-galactosidase A activity in blood samples collected on filter paper, leukocytes and plasma.
Daitx VV; Mezzalira J; Goldim MP; Coelho JC
Clin Biochem; 2012 Oct; 45(15):1233-8. PubMed ID: 22569598
[TBL] [Abstract][Full Text] [Related]
12. The effect of preparation, storage and shipping of dried blood spots on the activity of five lysosomal enzymes.
Elbin CS; Olivova P; Marashio CA; Cooper SK; Cullen E; Keutzer JM; Zhang XK
Clin Chim Acta; 2011 Jun; 412(13-14):1207-12. PubMed ID: 21419758
[TBL] [Abstract][Full Text] [Related]
13. Testing the feasibility of fully automated chip-based nanoelectrospray ionization mass spectrometry as a novel tool for rapid diagnosis of Fabry disease.
Flangea C; Mosoarca C; Cozma C; Galusca M; Przybylski M; Zamfir AD
Electrophoresis; 2013 Jun; 34(11):1572-80. PubMed ID: 23483567
[TBL] [Abstract][Full Text] [Related]
14. A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient population.
Merta M; Reiterova J; Ledvinova J; Poupetová H; Dobrovolny R; Rysavá R; Maixnerová D; Bultas J; Motán J; Slivkova J; Sobotova D; Smrzova J; Tesar V
Nephrol Dial Transplant; 2007 Jan; 22(1):179-86. PubMed ID: 17040996
[TBL] [Abstract][Full Text] [Related]
15. Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers.
Linthorst GE; Vedder AC; Aerts JM; Hollak CE
Clin Chim Acta; 2005 Mar; 353(1-2):201-3. PubMed ID: 15698608
[TBL] [Abstract][Full Text] [Related]
16. Comparing the alpha-galactosidase A biochemical properties from healthy individuals and Fabry disease patients.
Daitx VV; Mezzalira J; Moraes Vda C; Breier AC; Cé J; Coelho JC
Clin Chim Acta; 2015 May; 445():60-4. PubMed ID: 25804996
[TBL] [Abstract][Full Text] [Related]
17. Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platform.
Sista RS; Wang T; Wu N; Graham C; Eckhardt A; Winger T; Srinivasan V; Bali D; Millington DS; Pamula VK
Clin Chim Acta; 2013 Sep; 424():12-8. PubMed ID: 23660237
[TBL] [Abstract][Full Text] [Related]
18. Twelve different enzyme assays on dried-blood filter paper samples for detection of patients with selected inherited lysosomal storage diseases.
Civallero G; Michelin K; de Mari J; Viapiana M; Burin M; Coelho JC; Giugliani R
Clin Chim Acta; 2006 Oct; 372(1-2):98-102. PubMed ID: 16712827
[TBL] [Abstract][Full Text] [Related]
19. Whatman 3 MM dried blood spots for identifying alpha-thalassemia-1.
Tangvarasittichai O; Jongjitwimol J; Tangvarasittichai S
Clin Lab; 2008; 54(7-8):281-3. PubMed ID: 18942496
[TBL] [Abstract][Full Text] [Related]
20. Fabry disease: results of the first UK hemodialysis screening study.
Wallin EF; Clatworthy MR; Pritchard NR
Clin Nephrol; 2011 Jun; 75(6):506-10. PubMed ID: 21612753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
